Form 4: Omada Health CFO Granted 147,058 RSUs

Omada Health's Chief Financial Officer, Steven L. Cook, was granted 147,058 restricted stock units, vesting quarterly over four years.

Summary

• Steven L. Cook, Chief Financial Officer of Omada Health, Inc., was granted 147,058 Restricted Stock Units (RSUs).
• Each RSU represents the right to receive one share of Omada Health Common Stock upon vesting.
• The RSUs will vest in quarterly installments, with 1/16th vesting on each quarterly anniversary from March 1, 2026.
• Full vesting of all RSUs is expected by March 1, 2030.
• The transaction was executed on March 5, 2026, as part of a pre-arranged Rule 10b5-1 plan.
• Following this grant, Steven L. Cook beneficially owns 202,396 shares of Common Stock (including vested and unvested RSUs).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, primarily due to enhanced management alignment and retention, which are generally favorable for long-term shareholder value, despite minor future dilution.

Positives

• The RSU grant aligns the CFO's long-term interests with those of shareholders, incentivizing sustained performance.
• The vesting schedule promotes executive retention over a four-year period.
• The transaction was made pursuant to a Rule 10b5-1 plan, indicating a pre-arranged, transparent approach to insider transactions.

Negatives

• The issuance of new shares upon vesting of RSUs will result in a minor dilutive effect on existing shareholders over time.

Future Outlook

The filing indicates a future vesting schedule for the granted RSUs, with full vesting expected by March 1, 2030. This implies a long-term commitment of the CFO to the company.

Industry Context

StockSavvy.ai notes that equity compensation, particularly through Restricted Stock Units (RSUs) with multi-year vesting schedules, is a standard practice in the technology and healthcare sectors. This approach is widely used to attract, retain, and motivate key executives by aligning their financial incentives with the long-term performance of the company.

Comparison to Industry Standards

• The grant of 147,058 RSUs to a Chief Financial Officer with a four-year quarterly vesting schedule is consistent with typical executive compensation packages in growth-oriented technology and healthcare companies.
• For example, similar RSU grants and vesting structures are common at companies like Teladoc Health (TDOC) or Livongo Health (acquired by TDOC), where executive compensation often includes a significant equity component to incentivize long-term value creation.
• The $0 price for RSUs is standard as they represent a right to receive shares upon meeting vesting conditions, not a purchase.

Related Party Transactions

• The RSU grant to the Chief Financial Officer is a related party transaction, representing equity compensation from the company to an executive.

Stakeholder Impact

• Shareholders: Potential minor dilution over time as RSUs vest and convert to shares, but also benefits from increased executive alignment and retention.
• Employees: No direct impact mentioned, but executive compensation practices can influence overall company culture and compensation philosophy.
• Management: Steven L. Cook's compensation package is enhanced, providing a strong incentive for long-term performance and retention.

Next Steps

• The RSUs will vest in quarterly increments, with the first vesting occurring on a quarterly anniversary of March 1, 2026.
• The CFO will receive shares of Common Stock upon each vesting event.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a key executive, which is a standard practice for aligning management incentives with shareholder interests. While it signals executive retention and commitment, it does not present new information that would fundamentally alter the company's valuation or immediate operational outlook. Therefore, a 'hold' recommendation is appropriate as it reinforces existing investment theses without providing a catalyst for a significant re-evaluation.

Keywords

Omada Health, OMDA, Steven L. Cook, CFO, Restricted Stock Units, RSU, Insider Transaction, Form 4, Equity Compensation, Vesting, Rule 10b5-1